CZ20011796A3 - Pouľití N-substituovaných azabicycloalkanových derivátů pro léčení poruch centrálního nervového systému - Google Patents

Pouľití N-substituovaných azabicycloalkanových derivátů pro léčení poruch centrálního nervového systému Download PDF

Info

Publication number
CZ20011796A3
CZ20011796A3 CZ20011796A CZ20011796A CZ20011796A3 CZ 20011796 A3 CZ20011796 A3 CZ 20011796A3 CZ 20011796 A CZ20011796 A CZ 20011796A CZ 20011796 A CZ20011796 A CZ 20011796A CZ 20011796 A3 CZ20011796 A3 CZ 20011796A3
Authority
CZ
Czechia
Prior art keywords
azabicyclo
exo
ethyl
fluorophenyl
heptyl
Prior art date
Application number
CZ20011796A
Other languages
Czech (cs)
English (en)
Inventor
Rainer Munschauer
Gerd Steiner
Gerhard Gross
Martin Traut
Liliane Unger
Hans-Jürgen Teschendorf
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of CZ20011796A3 publication Critical patent/CZ20011796A3/cs

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
CZ20011796A 1998-11-24 1999-11-12 Pouľití N-substituovaných azabicycloalkanových derivátů pro léčení poruch centrálního nervového systému CZ20011796A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19854147A DE19854147A1 (de) 1998-11-24 1998-11-24 Verwendung von N-substituierten Azabicycloalkan-Derivaten zur Verwendung bei der Bekämpfung der Cocainsucht

Publications (1)

Publication Number Publication Date
CZ20011796A3 true CZ20011796A3 (cs) 2002-05-15

Family

ID=7888824

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20011796A CZ20011796A3 (cs) 1998-11-24 1999-11-12 Pouľití N-substituovaných azabicycloalkanových derivátů pro léčení poruch centrálního nervového systému

Country Status (21)

Country Link
EP (1) EP1133293A1 (bg)
JP (1) JP2002530333A (bg)
KR (1) KR20010080535A (bg)
CN (1) CN1328455A (bg)
AR (1) AR021502A1 (bg)
AU (1) AU1775300A (bg)
BG (1) BG105549A (bg)
BR (1) BR9915589A (bg)
CA (1) CA2352526A1 (bg)
CZ (1) CZ20011796A3 (bg)
DE (1) DE19854147A1 (bg)
HK (1) HK1040933A1 (bg)
HR (1) HRP20010472A2 (bg)
HU (1) HUP0104416A3 (bg)
IL (1) IL143181A0 (bg)
NO (1) NO20012538L (bg)
PL (1) PL348758A1 (bg)
SK (1) SK7112001A3 (bg)
TR (1) TR200101476T2 (bg)
WO (1) WO2000030639A1 (bg)
ZA (1) ZA200103976B (bg)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2589363A1 (en) 2004-12-13 2006-06-22 Eli Lilly And Company Spiro derivatives as lipoxygenase inhibitors
GB0812310D0 (en) 2008-07-03 2008-08-13 Syngenta Ltd Novel herbicides
MX2015009153A (es) * 2013-01-15 2016-03-04 Novartis Ag Uso de agonistas del receptor nicotinico de acetilcolina alfa 7.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0348460A4 (en) * 1987-11-12 1991-11-27 American Home Products Corporation Polycyclicamines with psychotropic activity
DE4427648A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-Stubstituierte 3-Azabicyclo[3,2,0,]heptan-Derivate, ihre Herstellung und Verwendung
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
DE4427647A1 (de) * 1994-08-04 1996-02-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
TR200101476T2 (tr) 2001-10-22
WO2000030639A1 (de) 2000-06-02
BG105549A (bg) 2001-12-29
CA2352526A1 (en) 2000-06-02
CN1328455A (zh) 2001-12-26
HUP0104416A2 (hu) 2002-04-29
HRP20010472A2 (en) 2003-04-30
BR9915589A (pt) 2001-08-07
HUP0104416A3 (en) 2002-11-28
EP1133293A1 (de) 2001-09-19
NO20012538D0 (no) 2001-05-23
AU1775300A (en) 2000-06-13
SK7112001A3 (en) 2001-12-03
NO20012538L (no) 2001-07-04
JP2002530333A (ja) 2002-09-17
IL143181A0 (en) 2002-04-21
DE19854147A1 (de) 2000-05-25
PL348758A1 (en) 2002-06-03
AR021502A1 (es) 2002-07-24
HK1040933A1 (zh) 2002-06-28
ZA200103976B (en) 2002-05-16
KR20010080535A (ko) 2001-08-22

Similar Documents

Publication Publication Date Title
AU2014227807B2 (en) Pharmaceutical composition comprising an AMPK activator and a serotonergic agent and methods of use thereof
US20200206188A1 (en) Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
Siddiqui et al. Antidepressant potential of nitrogen-containing heterocyclic moieties: an updated review
KR102427777B1 (ko) 디안하이드로갈락티톨, 디아세틸디안하이드로갈락티톨, 디브로모둘시톨, 또는 그의 유사체 또는 유도체를 이용하여 유전학적 다형성이 있는 환자에 있어서 티로신-키나아제-억제제 내성 악성종양, ahi1 조절곤란 또는 돌연변이를 치료하는 방법
ES2290741T3 (es) Metodo de tratamiento de trastornos del tracto urinario inferior.
EP2322162A1 (en) 5HT2C receptor modulator compositions and methods of use
US8541406B2 (en) Thiadiazole derivatives for the treatment of neurodegenerative diseases
SK286864B6 (sk) Použitie opticky čistého (S,S) reboxetínu alebo jeho farmaceuticky prijateľnej soli na výrobu lieku na liečenie alebo prevenciu fibromyalgie alebo iných somatoformných porúch
US20230248738A1 (en) Medicament for treating cough
KR20090005371A (ko) 폐경후 성욕 장애의 치료를 위한 플리반세린의 용도
TW202003508A (zh) 新穎的三唑酮衍生物或其鹽及包含彼等之醫藥組合物
US20230277552A1 (en) Pharmaceutical composition for preventing, suppressing, or treating symptom associated with allergic reaction
KR20080107429A (ko) 정신병적 장애의 치료 또는 예방용의 신규한 치료학적 배합물
CZ20011796A3 (cs) Pouľití N-substituovaných azabicycloalkanových derivátů pro léčení poruch centrálního nervového systému
KR100602976B1 (ko) 심리학적 장애의 치료를 위한 게피론의 생활성 대사물질의용도
JP2023065324A (ja) 抗特発性肺線維症剤
MXPA01005104A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
US20230120205A1 (en) Nerve cell degeneration inhibitor
US20240000795A1 (en) Methods and compositions relating to controlling psychedelic effects with serotonin receptor modulators
Slassi et al. Novel serotonergic and non-serotonergic migraine headache therapies
KR20080011400A (ko) 벤즈아제피늄 말레에이트 유도체의 결정질 형태
AU2007200317A1 (en) Method of treating lower urinary tract disorders
TW200412968A (en) 2,4,6-triaminopyrimidines for the treatment of depression and/or anxiety